TY - JOUR
T1 - N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection
AU - Ameen, S. Sadia
AU - Griem-Krey, Nane
AU - Dufour, Antoine
AU - Hossain, M. Iqbal
AU - Hoque, Ashfaqul
AU - Sturgeon, Sharelle
AU - Nandurkar, Harshal
AU - Draxler, Dominik F.
AU - Medcalf, Robert L.
AU - Kamaruddin, Mohd Aizuddin
AU - Lucet, Isabelle S.
AU - Leeming, Michael G.
AU - Liu, Dazhi
AU - Dhillon, Amardeep
AU - Lim, Jet Phey
AU - Basheer, Faiza
AU - Zhu, Hong Jian
AU - Bokhari, Laita
AU - Roulston, Carli L.
AU - Paradkar, Prasad N.
AU - Kleifeld, Oded
AU - Clarkson, Andrew N.
AU - Wellendorph, Petrine
AU - Ciccotosto, Giuseppe D.
AU - Williamson, Nicholas A.
AU - Ang, Ching Seng
AU - Cheng, Heung Chin
N1 - Publisher Copyright: © 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.
PY - 2023/5
Y1 - 2023/5
N2 - Excitotoxicity, a neuronal death process in neurological disorders such as stroke, is initiated by the over-stimulation of ionotropic glutamate receptors. Although dysregulation of proteolytic signaling networks is critical for excitotoxicity, the identity of affected proteins and mechanisms by which they induce neuronal cell death remain unclear. To address this, we used quantitative N-terminomics to identify proteins modified by proteolysis in neurons undergoing excitotoxic cell death. We found that most proteolytically processed proteins in excitotoxic neurons are likely substrates of calpains, including key synaptic regulatory proteins such as CRMP2, doublecortin-like kinase I, Src tyrosine kinase and calmodulin-dependent protein kinase IIβ (CaMKIIβ). Critically, calpain-catalyzed proteolytic processing of these proteins generates stable truncated fragments with altered activities that potentially contribute to neuronal death by perturbing synaptic organization and function. Blocking calpain-mediated proteolysis of one of these proteins, Src, protected against neuronal loss in a rat model of neurotoxicity. Extrapolation of our N-terminomic results led to the discovery that CaMKIIα, an isoform of CaMKIIβ, undergoes differential processing in mouse brains under physiological conditions and during ischemic stroke. In summary, by identifying the neuronal proteins undergoing proteolysis during excitotoxicity, our findings offer new insights into excitotoxic neuronal death mechanisms and reveal potential neuroprotective targets for neurological disorders.
AB - Excitotoxicity, a neuronal death process in neurological disorders such as stroke, is initiated by the over-stimulation of ionotropic glutamate receptors. Although dysregulation of proteolytic signaling networks is critical for excitotoxicity, the identity of affected proteins and mechanisms by which they induce neuronal cell death remain unclear. To address this, we used quantitative N-terminomics to identify proteins modified by proteolysis in neurons undergoing excitotoxic cell death. We found that most proteolytically processed proteins in excitotoxic neurons are likely substrates of calpains, including key synaptic regulatory proteins such as CRMP2, doublecortin-like kinase I, Src tyrosine kinase and calmodulin-dependent protein kinase IIβ (CaMKIIβ). Critically, calpain-catalyzed proteolytic processing of these proteins generates stable truncated fragments with altered activities that potentially contribute to neuronal death by perturbing synaptic organization and function. Blocking calpain-mediated proteolysis of one of these proteins, Src, protected against neuronal loss in a rat model of neurotoxicity. Extrapolation of our N-terminomic results led to the discovery that CaMKIIα, an isoform of CaMKIIβ, undergoes differential processing in mouse brains under physiological conditions and during ischemic stroke. In summary, by identifying the neuronal proteins undergoing proteolysis during excitotoxicity, our findings offer new insights into excitotoxic neuronal death mechanisms and reveal potential neuroprotective targets for neurological disorders.
UR - http://www.scopus.com/inward/record.url?scp=85160199666&partnerID=8YFLogxK
U2 - 10.1016/j.mcpro.2023.100543
DO - 10.1016/j.mcpro.2023.100543
M3 - مقالة
C2 - 37030595
SN - 1535-9476
VL - 22
JO - Molecular and Cellular Proteomics
JF - Molecular and Cellular Proteomics
IS - 5
M1 - 100543
ER -